AzTrials
AzTrials

Chronic Periodontitis ApicalNCT04763187

Post-extractive Alveolus Regeneration

A study testing Tooth extraction in people with Chronic Periodontitis Apical and Embedded Tooth, run by Lithuanian University of Health Sciences at 1 site in Lithuania.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Healing of post-extraction alveolus is a complex process that involves soft and hard tissues regeneration. Pain, swelling, difficulty of opening the mouth, delayed healing of bone tissue, alveolitis and horizontal or vertical resorption of bone tissue are the main problems that have impact on consequent treatment. Read more about this study

Who is it for?
Ages 18 to 50 years
Conditions the study is for
Chronic Periodontitis Apical, Embedded Tooth
What is being tested?
Tooth extraction
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
43 participants
Where
1 siteLithuania
Study dates
1 Sep 2019to 29 Jan 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Patients who need lower molar extraction
  • Patients who belong to working age group (18-50 years)

Who cannot join

  • Pregnant women and postmenopausal women
  • Children and older than 50 years old patients
  • Oncological diseases, undergone chemotherapy and radiation therapy
  • Chronic diseases
  • Hormonal imbalances
  • Somatic symptom disorder
Show all 10Show fewer
  • Osteoporosis, osteonecrosis
  • Taking bisphosphonates, antidepressants, psychotropic drugs
  • Smoking
  • Psychologically dissabled patients

Trial locations and contacts

1 site in 1 country.

Lithuania1 site
  • Lithuanian University of Health Sciences

    Kaunas

Other trials in Lithuania

About this study

Official title: Influence of PRGF and PRF on Post-extractive Alveolus Regeneration. Randomised Controlled Trial

Healing of post-extraction alveolus is a complex process that involves soft and hard tissues regeneration. Pain, swelling, difficulty of opening the mouth, delayed healing of bone tissue, alveolitis and horizontal or vertical resorption of bone tissue are the main problems that have impact on consequent treatment. Blood concentrates PRGF (plasma rich in growth factors) and PRF (platelet-rich fibrin), which are rich in growth factors, create better conditions for post-extraction alveolus healing and enhance quality of soft tissues and bone regeneration. Our study objective was to compare physiological healing of post-extraction zone, PRF and PRGF induced changes of healing process. Methods that we used: 43 patients were randomly divided into 3 groups: I control group - lower molar extraction and filling of post-extraction alveolus with hemostatic sponge containing gentamicin, II group - post-extraction alveolus is filled PRGF and III group - post-extraction alveolus is filled with PRF. Bone regeneration was evaluated in CBCT scans after 1 month. Pain was evaluated using visual analogical scale (VAS).

Read the detailed description

This was a prospective, single-centre, with unequal randomisation ratio [1,9:1:1], parallel, multiple-group (control and two experimental groups) study. Randomized clinical trial was conducted between September 2019 and December 2019 at department of Maxillofacial Surgery Clinic of Kaunas Clinics. Permission of Bioethics Center was acquired for this study. Participants of this study were patients who needed extraction of lower molars due to K04.5 (chronic apical periodontitis) and K01.0 (embedded teeth) diagnoses, based on ICD-10-CM classification. In this study participated 43 patients: 33 (76,7%) women and 10 (23,3%) men, average age - 28,6 years, the youngest was 18 years old and the oldest was 48 years old. All patients were introduced to the study protocol and gave informed consent. Confidentiality of subjects is assured because only summarized results will be published.

Patients were randomised into 3 groups: I control group - lower molar extraction and filling of post-extraction alveolus with hemostatic sponge containing gentamicin, II group - post-extraction alveolus is filled PRGF and III group - post-extraction alveolus is filled with PRF. Randomization sequence was created using Excel 2019 (Microsoft, Redmond, WA, USA) with a 1,9:1:1 allocation using random block sizes of 2 and 4. Surgery was performed by the same surgeon. After procedures of tooth extraction and PRGF or PRF application, zone of surgery was closed up using resorbable thread (Ethicon Coated Vicryl Plus 4-0) and applying the method of cross mattress suture. During procedure control group was administred with local antibiotics (gentamicin) to avoid infection possibility. Non-steroidal anti-inflammatory medication was administered one hour after procedure and before sleep. Threads were removed after 7 days. Pain felt on 1st and on 7th day after procedure was evaluated using visual analogical scale (hereinafter - VAS) during the same appointment. Pacients selected number from 0 to 10, there accordingly 0 - no pain, 5 - moderate pain and 10 - worst pain. [22] Cone beam computed tomography (hereinafter - CBCT) (E-WOO, Picasso Trio, Republic of Korea) was carried out immediately after procedure and 1 month after procedure for evaluation of bone tissue regeneration. It was decided to evaluate bone regeneration in CBCT scans (Ez3D Plus Professional Ver.1.2.6.1) at following dimensions: horizontal AA (X) (mm) and vertical AA (Y) (mm) dimensions of alveolar ridge were measured. Also, horizontal X (mm), vertical Y (mm) and diagonal Z (mm) dimensions of primary bone tissue formed in post-extraction alveolus in 1 month (Figure 2) All measurements carried out by the same examinator.

Sample size of this study was calculated by using Paniotto formula. During the research period (September to December 2019) was estimated that on average within 4 months 48 pacients applies to department of Maxillofacial Surgery Clinic of Kaunas Clinics due to lower molars extraction. After calculations with 95% probability and 0,05 error defined required sample size - 43 pacients.

Statistical analysis carried out using SPSS (Statistical Package for the Social Science for Windows; Chihago, USA) package 22.0. The diagnostic and demographic charasteristics were compared using Wilcoxon test, Kruskal-Wallis test, Mann-Whitney test and Spearman correlation analysis. Level of significance p was set at 0,05 for verification of statistical hypotheses.

Blood of 11 patients (3 men and 8 women, average age 27 years) taken from peripheral vein, using 21G blood collection needle and PRGF-Endoret® test tubes with volume of 9 ml, for production of PRGF. As per instruction of manufacturer, tubes contain 3,8 % sodium citrate, which serves as anticoagulant. In order to produce the PRGF, test tubes were centrifuged for 8 minutes in 580 g Endoret® (PRGF®) System V centrifuge. 3 different layers are formed - erythrocytes, leukocytes and blood plasma. Layer of blood plasma is divided into two fractions. 1st fraction is called plasma poor in growth factors, which forms a top layer in a tube down to 2nd fraction. 2nd fraction (2 ml of blood plasma, which is above the layer of leukocytes), forms the layer of plasma rich in growth factors. Activation of this fraction is carried out using sterile 10 % calcium chloride solution (50 µL of activator for 1 ml of blood plasma), which carried out degranulation of platelets and therefore released growth factors. After activation, test tubes were incubated at 37°C for 30 minutes, in order give the consistency of gelatin to PRGF. Formed fold or fluid was inserted into alveolus of extracted tooth, then the edges were closed up using resorbable cross mattress suture.

Blood of 11 patients (2 men and 9 women, average age 26 years) were collected from peripheral vein using 21G blood collection needle and PRF test tubes with volume of 9 ml, for production of PRF. Test tube was inserted into A-PRF centrifuge "A-PRF 12". The lid was closed and program at 2800 rpm for 12 minutes was initiated. A-PRF fold was separated from red blood cells (blood clots) in the test tube. After pulling the fold out of test tube, it was formed on sterile surgical tray. Formed fold was inserted into alveolus of extracted tooth and edges of wound were closed up using resorbable cross mattress suture.

Being tested
Tooth extraction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Tooth extractionProcedure or surgery

    Tooth extraction and alveolus regeneration with autologous blood concentrate.

Study groups in NCT04763187
Study groupRoleWhat they receive
Control groupActive comparatorLower molar extraction and filling of post-extraction alveolus with hemostatic sponge containing gentamicin.
Receives: Procedure: Tooth extraction
PRGF groupExperimentalPost-extraction alveolus is filled with PRGF.
Receives: Procedure: Tooth extraction
PRF groupExperimentalPost-extraction alveolus is filled with PRF.
Receives: Procedure: Tooth extraction

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Post operative pain

    Pain was evaluated using visual analogical scale (VAS). Pacients selected number from 0 to 10, there accordingly 0 - no pain, 5 - moderate pain and 10 - worst pain.

    Measured: First day after surgery.

  2. Post operative pain

    Pain was evaluated using visual analogical scale (VAS). Pacients selected number from 0 to 10, there accordingly 0 - no pain, 5 - moderate pain and 10 - worst pain.

    Measured: Seventh day after surgery.

  3. Bone regeneration

    Bone regeneration was evaluated in CBCT scans. In CBCT scans (Ez3D Plus Professional Ver.1.2.6.1) immediately after surgery horizontal (mm) and vertical (mm) dimensions of alveolar ridge were measured.

    Measured: Immediately after surgery.

  4. Bone regeneration

    Bone regeneration was evaluated in CBCT scans. In CBCT scans (Ez3D Plus Professional Ver.1.2.6.1) 1 month after surgery horizontal (mm) and vertical (mm) dimensions of alveolar ridge were measured. Also, horizontal (mm), vertical (mm) and diagonal (mm) dimensions of primary bone tissue formed in post-extraction alveolus in 1 month.

    Measured: 1 month after surgery.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Feb 2021
  2. Study start1 Sep 2019
  3. Primary completion29 Dec 2019
  4. Study completion29 Jan 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
43 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04763187
Sponsor's protocol ID
LSMU123
Status last verified
Feb 2021
First submitted
16 Feb 2021
Last updated
21 Feb 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Tooth extraction in people with Chronic Periodontitis Apical and Embedded Tooth, run by Lithuanian University of Health Sciences at 1 site in Lithuania.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Feb 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Lithuania. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Post operative pain (time frame: First day after surgery.). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Feb 2021.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in